Phase 1-2 study of the association of Gemzar-cisplatin-concurrent radiotherapy in patients with non-metastatic tumors of the bladder

Trial Profile

Phase 1-2 study of the association of Gemzar-cisplatin-concurrent radiotherapy in patients with non-metastatic tumors of the bladder

Completed
Phase of Trial: Phase I/II

Latest Information Update: 03 Aug 2015

At a glance

  • Drugs Gemcitabine (Primary) ; Cisplatin
  • Indications Bladder cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 05 Mar 2010 Phase I results (n=14) presented at ASCO Genitourinary Cancers Symposium 2010.
    • 18 Dec 2009 Planned end date (1 Apr 2010) added as reported by ClinicalTrials.gov.
    • 20 Nov 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top